# Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease

> **NCT00967681** · PHASE3 · COMPLETED · sponsor: **Catalysis SL** · enrollment: 200 (actual)

## Conditions studied

- Breast Fibrocystic Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Oncoxin
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT00967681
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2012-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00967681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00967681, "Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00967681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*